Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AMED CoROCO:7575 -0.50%52 PS Ratio is 0.37 as of Jul. 23, 2026, which is 84% below its 10-year median of 2.25. GuruFocus rates ROCO:7575 with a GF Score™ of 52/100 and a GF Value™ of NT$62.82 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 804 Medical Devices & Instruments companies, AMED Co ranks better than 94.15% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, AMED Co's share price is NT$10.05.
AMED Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$27.32. Hence, AMED Co's PS Ratio for today is 0.37.
Good Sign:
AMED Co Ltd stock PS Ratio (=0.37) is close to 5-year low of 0.37.
The historical rank and industry rank for AMED Co's PS Ratio or its related term are showing as below:
ROCO:7575'
s PS Ratio Range Over the Past 10 Years
Min: 0.37 Med: 2.25 Max: 3.27
Current: 0.37
During the past 7 years, AMED Co's highest PS Ratio was 3.27. The lowest was 0.37. And the median was 2.25.
ROCO:7575's PS Ratio is ranked better than 94.15% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.825
vs ROCO:7575: 0.37
AMED Co's Revenue per Sharefor the
six
months ended in Dec. 2025 was NT$13.97.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$27.32.
Warning Sign:
AMED Co Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of AMED Co was 0.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 6.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 12.10% per year.
During the past 7 years, AMED Co's highest 3-Year average Revenue per Share Growth Rate was 17.00% per year. The lowest was 6.00% per year. And the median was 12.30% per year.
Back to Basics: PS Ratio
AMED Co (ROCO:7575) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
AMED Co PS Ratio Related Terms
AMED Co PS Ratio Historical Data
* Premium members only.
The historical data trend for AMED Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, AMED Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AMED Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AMED Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where AMED Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
AMED Co's Share Price of today is NT$10.05.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AMED Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$27.32.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
AMED Co (ROCO:7575) has a PS Ratio of 0.37 as of Jul. 23, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on AMED Co and its competitors. This is 84% below median its historical median of 2.25. Over the past decade, AMED Co's PS Ratio has ranged from 0.37 to 3.27. According to the industry distribution chart, AMED Co ranks #47 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 5.8%.
Is AMED Co's PS Ratio too high?
AMED Co's current PS Ratio of 0.37 is 84% below median its 10-year median of 2.25. Over the past 10 years, this metric has ranged from a low of 0.37 to a high of 3.27. The Medical Devices & Instruments industry median PS Ratio is 2.83. AMED Co's value of 0.37 is 86.9% below this industry median. Based on the distribution chart, AMED Co ranks #47 out of 804 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, AMED Co has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AMED Co's PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, AMED Co ranks #47 out of 804 companies for PS Ratio. This places AMED Co in the top 6% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.83. AMED Co's value of 0.37 is 86.9% below this benchmark. Historically, AMED Co's own PS Ratio has ranged from 0.37 to 3.27 over the past decade. While the company's 10-year median is 2.25 vs. the industry median of 2.83, AMED Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.83, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AMED Co's current PS Ratio of 0.37 is 86.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on AMED Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AMED Co's current PS Ratio is 0.37, which is 84% below median its own 10-year median of 2.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AMED Co stock overvalued right now?
Based on GuruFocus' analysis, AMED Co (ROCO:7575) is currently considered Possible Value Trap. The stock's GF Value™ is NT$62.82, compared to a current price of NT$10.05 — trading 84% below its estimated fair value. The current PS Ratio is 0.37, which is 84% below median its 10-year median of 2.25 and 86.9% below the Medical Devices & Instruments industry median of 2.83. AMED Co's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For AMED Co (ROCO:7575), the current PS Ratio is 0.37 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AMED Co (ROCO:7575) Overvalued in 2026?
Based on GuruFocus' analysis, AMED Co stock appears to be undervalued.
The current stock price of NT$10.05 is trading 84% below its estimated GF Value™ of NT$62.82.
GuruFocus considers AMED Co to be Possible Value Trap.
Key valuation signals for ROCO:7575:
PS Ratio: 0.37 (84% below median its 10-year median of 2.25)
GF Value™: NT$62.82 vs. price of NT$10.05 (84% below fair value)
Industry Position: 86.9% below the Medical Devices & Instruments median (#47 of 804)
No single metric tells the full story. See the ROCO:7575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.
52GF Score
Get the complete analysis for ROCO:7575
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7575 has been successfully added to your 
